Skip to main content
Premium Trial:

Request an Annual Quote

Agilent, Covaris Strike Co-Marketing Pact for Sequencing Techs

NEW YORK (GenomeWeb News) – Agilent Technologies and Covaris have struck a co-marketing agreement for their target enrichment and DNA shearing technologies for next-generation sequencing studies, Agilent said today.

Under the agreement, the Covaris S2 DNA shearing technology will be marketed with Agilent's SureSelect Target Enrichment System to researchers using next-generation sequencing.

The Covaris technology uses the firm's Adaptive Focused Acoustic method for biological and chemical sample preparation, and it provides a "predictable and reproducible" DNA shearing method that can limit the amount of DNA lost in the process, the company said.

As part of the agreement, Covaris has developed a SureSelect Accessory Kit to help integrate the Agilent and Covaris workflows, Agilent said.

The companies will continue to work together to develop new protocols and products for the SureSelect and Covaris S2 systems, the partners added.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.